65 related articles for article (PubMed ID: 19616540)
1. Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models.
Issandou M; Bouillot A; Brusq JM; Forest MC; Grillot D; Guillard R; Martin S; Michiels C; Sulpice T; Daugan A
Eur J Pharmacol; 2009 Sep; 618(1-3):28-36. PubMed ID: 19616540
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity.
McNamara RK; Jandacek R; Rider T; Tso P; Cole-Strauss A; Lipton JW
Schizophr Res; 2011 Jun; 129(1):66-73. PubMed ID: 21474290
[TBL] [Abstract][Full Text] [Related]
3. FADS2 confers SCD1 inhibition resistance to cancer cells by modulating the ER stress response.
Ikeda T; Katoh Y; Hino H; Seta D; Ogawa T; Iwata T; Nishio H; Sugawara M; Hirai S
Sci Rep; 2024 Jun; 14(1):13116. PubMed ID: 38849435
[TBL] [Abstract][Full Text] [Related]
4. 1H NMR-based lipidomics of rodent fur: species-specific lipid profiles and SCD1 inhibitor-related dermal toxicity.
Khandelwal P; Stryker S; Chao H; Aranibar N; Lawrence RM; Madireddi M; Zhao W; Chen L; Reily MD
J Lipid Res; 2014 Jul; 55(7):1366-74. PubMed ID: 24755647
[TBL] [Abstract][Full Text] [Related]
5. SCD1 and monounsaturated lipids are required for autophagy and survival of adipocytes.
Mori H; Peterson SK; Simmermon R; Overmyer KA; Nishii A; Paulsson E; Li Z; Jen A; Uranga RM; Maung J; Yacawych WT; Lewis KT; Schill RL; Hetrick T; Seino R; Inoki K; Coon JJ; MacDougald OA
bioRxiv; 2023 Oct; ():. PubMed ID: 37961537
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438).
Léger S; Black WC; Deschenes D; Dolman S; Falgueyret JP; Gagnon M; Guiral S; Huang Z; Guay J; Leblanc Y; Li CS; Massé F; Oballa R; Zhang L
Bioorg Med Chem Lett; 2010 Jan; 20(2):499-502. PubMed ID: 20004097
[TBL] [Abstract][Full Text] [Related]
7. SCD1 negatively regulates autophagy-induced cell death in human hepatocellular carcinoma through inactivation of the AMPK signaling pathway.
Huang GM; Jiang QH; Cai C; Qu M; Shen W
Cancer Lett; 2015 Mar; 358(2):180-190. PubMed ID: 25528629
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel SCD1 inhibitors: 5-alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4'-piperidine] analogs.
Uto Y; Ueno Y; Kiyotsuka Y; Miyazawa Y; Kurata H; Ogata T; Takagi T; Wakimoto S; Ohsumi J
Eur J Med Chem; 2011 May; 46(5):1892-6. PubMed ID: 21356569
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A
Wretlind A; Zobel EH; de Zawadzki A; Ripa RS; Curovic VR; von Scholten BJ; Mattila IM; Hansen TW; Kjær A; Vestergaard H; Rossing P; Legido-Quigley C
Front Clin Diabetes Healthc; 2022; 3():856485. PubMed ID: 36992761
[TBL] [Abstract][Full Text] [Related]
10. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence.
Jeyakumar SM; Vajreswari A
World J Hepatol; 2022 Jan; 14(1):168-179. PubMed ID: 35126846
[TBL] [Abstract][Full Text] [Related]
11. The New Therapeutic Approaches in the Treatment of Non-Alcoholic Fatty Liver Disease.
Filipovic B; Lukic S; Mijac D; Marjanovic-Haljilji M; Vojnovic M; Bogdanovic J; Glisic T; Filipovic N; Al Kiswani J; Djokovic A; Kapor S; Kapor S; Bukumiric Z; Starcevic A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948020
[TBL] [Abstract][Full Text] [Related]
12. Current treatment paradigms and emerging therapies for NAFLD/NASH.
Raza S; Rajak S; Upadhyay A; Tewari A; Anthony Sinha R
Front Biosci (Landmark Ed); 2021 Jan; 26(2):206-237. PubMed ID: 33049668
[TBL] [Abstract][Full Text] [Related]
13. Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment.
Chen MM; Cai JJ; Yu Y; She ZG; Li H
Gene Expr; 2019 Nov; 19(3):175-185. PubMed ID: 30940296
[TBL] [Abstract][Full Text] [Related]
14. Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice.
Hou PH; Chang GR; Chen CP; Lin YL; Chao IS; Shen TT; Mao FC
Iran J Basic Med Sci; 2018 May; 21(5):495-501. PubMed ID: 29922430
[TBL] [Abstract][Full Text] [Related]
15. Vitamin A Improves Hyperglycemia and Glucose-Intolerance through Regulation of Intracellular Signaling Pathways and Glycogen Synthesis in WNIN/GR-Ob Obese Rat Model.
Jeyakumar SM; Sheril A; Vajreswari A
Prev Nutr Food Sci; 2017 Sep; 22(3):172-183. PubMed ID: 29043214
[TBL] [Abstract][Full Text] [Related]
16. Therapies in non-alcoholic steatohepatitis (NASH).
Oseini AM; Sanyal AJ
Liver Int; 2017 Jan; 37 Suppl 1(Suppl 1):97-103. PubMed ID: 28052626
[TBL] [Abstract][Full Text] [Related]
17. Hepatic and Whole-Body Insulin Metabolism during Proestrus and Estrus in Mongrel Dogs.
Yu EN; Winnick JJ; Edgerton DS; Scott MF; Smith MS; Farmer B; Williams PE; Cherrington AD; Moore MC
Comp Med; 2016; 66(3):235-40. PubMed ID: 27298249
[TBL] [Abstract][Full Text] [Related]
18. Impact of insulin deprivation and treatment on sphingolipid distribution in different muscle subcellular compartments of streptozotocin-diabetic C57Bl/6 mice.
Zabielski P; Blachnio-Zabielska A; Lanza IR; Gopala S; Manjunatha S; Jakaitis DR; Persson XM; Gransee J; Klaus KA; Schimke JM; Jensen MD; Nair KS
Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E529-42. PubMed ID: 24368672
[TBL] [Abstract][Full Text] [Related]
19. Increased lipid synthesis and decreased β-oxidation in the liver of SHR/NDmcr-cp (cp/cp) rats, an animal model of metabolic syndrome.
Tanaka S; Yamazaki T; Asano S; Mitsumoto A; Kobayashi D; Kudo N; Kawashima Y
Lipids; 2013 Nov; 48(11):1115-34. PubMed ID: 24045975
[TBL] [Abstract][Full Text] [Related]
20. Sterculic Oil, a Natural SCD1 Inhibitor, Improves Glucose Tolerance in Obese ob/ob Mice.
Ortinau LC; Pickering RT; Nickelson KJ; Stromsdorfer KL; Naik CY; Haynes RA; Bauman DE; Rector RS; Fritsche KL; Perfield JW
ISRN Endocrinol; 2012; 2012():947323. PubMed ID: 23209931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
